B and T lymphocyte attenuator tempers early infection immunity
about
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationInduction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate ImmunityHerpesvirus exploitation of host immune inhibitory pathwaysBTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infectionB and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.Functional interaction between herpes simplex virus type 2 gD and HVEM transiently dampens local chemokine production after murine mucosal infectionExhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections.A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitisRegulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling.CD160 is essential for NK-mediated IFN-γ productionTumor necrosis factor superfamily in innate immunity and inflammation.Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea.Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.Herpes virus entry mediator licenses Listeria infection induced immunopathology through control of type I interferon.Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort studyThe signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulationBTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccineThe intrahepatic expression and distribution of BTLA and its ligand HVEM in patients with HBV-related acute-on-chronic liver failure.B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesA new role for T cells in dampening innate inflammatory responses.Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T-lymphoproliferative disorders: brief review.Co-inhibitory molecules: Controlling the effectors or controlling the controllers?Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.A BTLA-mediated bait and switch strategy permits Listeria expansion in CD8α(+) DCs to promote long-term T cell responses.Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3.
P2860
Q24652965-85A7329B-F914-465C-9ECE-4A65E569811CQ26781290-DD1203CC-68F4-49E2-97A9-7A015C569502Q27013680-027F4F1C-64C2-4CF1-92CF-26E8EC869F57Q27303620-581E3CD5-8FD0-449A-B75D-FBE2FBC6533FQ33753374-C09C054F-20C0-4541-B2C1-4D847EC1058DQ33808866-CF79028D-4278-40C7-A455-5D9A7B06D5F2Q34042686-D8AC9DE6-679B-46E7-B211-7A5F40AAB079Q34248602-906189A6-80AB-452D-A207-51A6C193C09AQ34683637-812D0F22-9277-4D2C-8AA4-54749B98EBB7Q35161483-AE930DBA-DBF9-4D47-BFA8-C415C9A01531Q35245316-CDE5CCF3-3723-4F65-94E8-9355474D5F19Q35382403-1C7A8D42-1C9B-4793-8348-1FB821BBF07FQ35559497-E83FE66A-AA38-4689-8CD0-C8174D5788D9Q35922058-FDAC2A83-29E5-4C5B-A7B7-0CE1E00256ABQ36016266-2899E839-FE25-4892-9811-5759241EE31AQ36053977-F76D6DD6-D4AB-45BD-9540-4E174F8E5440Q36260550-679CDA9C-E79D-4463-9DF6-03019A9F4AD9Q36369605-4C97C40E-C346-42AB-8525-DDD08FDCC22FQ36729527-BFBB91E7-E973-496D-84D8-9481E416ECF3Q36940326-81F4931C-B772-45EC-8DD2-634D1613B79FQ37769443-878AC23F-7A83-4477-9805-5CB4813D5118Q38137911-11355A65-7A26-4CE5-8EF4-0AD5D98ED1ACQ39761212-CE14722D-8C5E-4217-A41B-1C441C553811Q40204862-7957F7CF-874A-4CD6-B0CD-C98AD44F43A6Q41897433-2E794BD8-A8AF-4472-8A83-C7CB29C35FF6Q41919014-3DA93DC1-4036-4668-95D9-A55375EFCB4FQ42841151-8E802E95-51E2-42A8-90B8-BF013CA31F40Q45357341-06CA2E34-6FB2-4482-B1A0-7D123AE0BC66
P2860
B and T lymphocyte attenuator tempers early infection immunity
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
B and T lymphocyte attenuator tempers early infection immunity
@ast
B and T lymphocyte attenuator tempers early infection immunity
@en
type
label
B and T lymphocyte attenuator tempers early infection immunity
@ast
B and T lymphocyte attenuator tempers early infection immunity
@en
prefLabel
B and T lymphocyte attenuator tempers early infection immunity
@ast
B and T lymphocyte attenuator tempers early infection immunity
@en
P2093
P2860
P50
P356
P1476
B and T lymphocyte attenuator tempers early infection immunity
@en
P2093
Jonathan Kaye
Kenneth M Murphy
Lieping Chen
Matthew J Ruddy
Mendy L Miller
Yonglian Sun
Youjin Lee
P2860
P304
P356
10.4049/JIMMUNOL.0801866
P407
P577
2009-07-08T00:00:00Z